PT - JOURNAL ARTICLE ED - , TI - New topical drugs for open-angle glaucoma AID - 10.1136/dtb.2003.41212 DP - 2003 Feb 01 TA - Drug and Therapeutics Bulletin PG - 12--14 VI - 41 IP - 2 4099 - http://dtb.bmj.com/content/41/2/12.short 4100 - http://dtb.bmj.com/content/41/2/12.full SO - Drug Ther Bull2003 Feb 01; 41 AB - Relevant BNF section: 11.6When we reviewed the management of open-angle glaucoma in 1997,1 the topical drug treatments available included beta-blockers, a carbonic anhydrase inhibitor (dorzolamide), an alpha2 agonist (apraclonidine), a prostaglandin analogue (latanoprost) and a variety of miotics and sympathomimetics. We concluded that a beta-blocker was the treatment of first choice. Here, we review seven new topical preparations that have been marketed, or had their licensed indications changed, since our earlier article.